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Effect of Palmitic and Oleic Acids 
on B2 Receptor Expression In 
Airway Smooth Muscle Cells
John Magagna, Deepak Deshpande PhD.*, and Ajay Nayak PhD.
Introduction
• Obese people are more likely to have asthma1 and nearly 
60% of adults with asthma are obese. 2 B2 agonists are often 
used as a rescue treatment when symptomatic. Obese 
patients are far more likely to be hospitalized for symptoms 
that are unable to be controlled by this rescue treatment. 3 
• The project is an attempt to understand how exposure to 
fatty acids will affect expression of the B2 receptor in airway 
smooth muscle cells with the goal of improving the primary 




– How do B2 receptor expression levels in airway 
smooth muscle cells exposed to Palmitic Acid and 
Oleic Acid compare to airway smooth muscle cells 
that are Untreated?
• Hypothesis
– B2 receptor expression will decrease in airway 
smooth muscle cells exposed to Palmitic acid 
compared to Untreated airway smooth muscle cells.
• B2 receptor expression will not change in airway smooth 
muscle cells exposed to Oleic Acid compared to Untreated 
airway smooth muscle cells.
Approach & Results
• The study was a Basic Science Cell Study 
design using airway smooth muscle cells.
• Interventions included cell treatments with 
fatty acids at varying concentrations.
• Airway smooth muscle cells were plated into 
six well dishes and treated according to the 
table below:
Note: BSA is agent used to dissolve Palmitic Acid for treatments 
and serves as our Untreated control for Palmitic Acid conditions
Approach & Results
• Cells were lysed and RNA was harvested at 24 
and 48 hours.
• Primers (B2, GAPDH) were used to expand 
selected RNA with PCR.
• RT PCR was used to quantify B2 and GAPDH 
expression, which served as an expression control 
for B2.
• This approach allowed for easy access to 
measuring B2 receptor RNA expression levels at 
precise fatty acid concentrations to see if these 
levels differed significantly from their controls.
Approach & Results
• Analysis 
– An unpaired T test was performed to assess for statistical difference in each 
condition compared to its control.  No p value was less than .05 so none of the 
conditions varied significantly from its control. 
Conditions dCqs of Means P Values For Each Condition
Control 24 16.51977044
BSA 24 15.72458217
P100 24 15.25812426 0.464354253
P200 24 15.60435946 0.866620192
O100 24 16.20325983 0.53839965
O200 24 16.49306651 0.96214382
Control 48 16.75581912
BSA 48 16.16316445
P100 48 15.16216097 0.143074353
O100 48 15.48294556 0.184299933
O200 48 16.64999384 0.824403539
Note: dCq= RT PCR cycles to reach threshold for B2- RT PCR cycles to reach threshold for GAPDH. P200 48 condition was excluded due to cell death.
Approach & Results
This graph shows the difference in cycle numbers to reach threshold of B2 and GAPDH for the means of each 
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Conclusions
• None of the conditions differed significantly from their controls. 
• This data does not support our main hypothesis that B2 receptor 
expression will decrease in cells exposed to Palmitic Acid. 
• Our secondary hypothesis that B2 receptor expression would be 
unchanged in cells treated with Oleic Acid is supported by our 
data.
• There is no current literature involving B2 expression in fatty acid 
exposed cells, so this is a new area for study with our data 
showing no significant decrease in expression for cells treated
with Palmitic or Oleic Acids.  
• There is further need for research into understanding the 
mechanism causing decreased efficacy of B2 agonists rescue 
treatments in obese patients.
Future Directions
• Further Clinical and Basic Science research 
into the mechanism of decreased efficacy of 
B2 agonists in obese patients is necessary.
• The next step for our team is a literature 
review to look for other possible mechanisms 
that may include changes in membrane 
fluidity due to fatty acid composition or 
changes in how B2 agonists interacts with 
receptors in these patients. 
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